New Qnostics SARS-CoV-2 Control
The Qnostics SARS-CoV-2 Medium Q control is designed to ensure the accuracy and reliability of molecular assays used in diagnostic testing for covid-19.
Read MorePosted by | Apr 22, 2020 | Controls, Covid 19, Emerging & Zoonotic Diseases, Infectious Diseases, Quality Systems |
The Qnostics SARS-CoV-2 Medium Q control is designed to ensure the accuracy and reliability of molecular assays used in diagnostic testing for covid-19.
Read MorePosted by | Apr 22, 2020 | Covid 19, Emerging & Zoonotic Diseases, Infectious Diseases |
Purdue’s animal disease diagnostic laboratory has received CLIA certification to conduct human diagnostic testing for covid-19.
Read MorePosted by | Apr 22, 2020 | Covid 19, Emerging & Zoonotic Diseases, Hematology & Serology, Infectious Diseases, Serology Instrumentation |
The Elecsys Anti-SARS-CoV-2 serology test will support the detection of antibodies against SARS-CoV-2 in patients who have been exposed to the virus.
Read MorePosted by | Apr 21, 2020 | Covid 19, Emerging & Zoonotic Diseases, Infectious Diseases |
The covid-19 test kit employs a single tube, and uses alveolar fluid, throat swab, or sputum samples to detect the virus, delivering results within hours.
Read MorePosted by | Apr 20, 2020 | Covid 19, Emerging & Zoonotic Diseases, Infectious Diseases |
Inspirata is offering its remote pathology initiative free to healthcare institutions looking to provide flexibility to their staff during the covid-19 pandemic.
Read More